Nothing Special   »   [go: up one dir, main page]

ATE490314T1 - Verfahren zur förderung der homologen rekombination somatischer zellen und verfahren zur konstruktion eines spezifischen antikörpers - Google Patents

Verfahren zur förderung der homologen rekombination somatischer zellen und verfahren zur konstruktion eines spezifischen antikörpers

Info

Publication number
ATE490314T1
ATE490314T1 AT03771393T AT03771393T ATE490314T1 AT E490314 T1 ATE490314 T1 AT E490314T1 AT 03771393 T AT03771393 T AT 03771393T AT 03771393 T AT03771393 T AT 03771393T AT E490314 T1 ATE490314 T1 AT E490314T1
Authority
AT
Austria
Prior art keywords
homologous recombination
antibody
constructing
promoting
specific antibody
Prior art date
Application number
AT03771393T
Other languages
English (en)
Inventor
Kunihiro Ohta
Hidetaka Seo
Takehiko Shibata
Original Assignee
Riken
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken, Japan Science & Tech Agency filed Critical Riken
Application granted granted Critical
Publication of ATE490314T1 publication Critical patent/ATE490314T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03771393T 2002-07-30 2003-07-28 Verfahren zur förderung der homologen rekombination somatischer zellen und verfahren zur konstruktion eines spezifischen antikörpers ATE490314T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002221232 2002-07-30
PCT/JP2003/009563 WO2004011644A1 (ja) 2002-07-30 2003-07-28 体細胞相同組換えの促進方法及び特異的抗体の作製方法

Publications (1)

Publication Number Publication Date
ATE490314T1 true ATE490314T1 (de) 2010-12-15

Family

ID=31184846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03771393T ATE490314T1 (de) 2002-07-30 2003-07-28 Verfahren zur förderung der homologen rekombination somatischer zellen und verfahren zur konstruktion eines spezifischen antikörpers

Country Status (7)

Country Link
US (2) US7776599B2 (de)
EP (1) EP1536004B1 (de)
JP (1) JP4214234B2 (de)
CN (1) CN100379862C (de)
AT (1) ATE490314T1 (de)
DE (1) DE60335191D1 (de)
WO (1) WO2004011644A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004085644A2 (en) * 2003-03-26 2004-10-07 Basf Plant Science Gmbh Method for producing recombinant organisms
CN101052728A (zh) * 2004-11-08 2007-10-10 独立行政法人理化学研究所 高效选出特异性地结合于配体的蛋白质的方法
JP4482693B2 (ja) * 2005-08-29 2010-06-16 国立大学法人 岡山大学 抗体産生細胞の特異的選択方法
WO2007049567A1 (ja) * 2005-10-24 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. 物質の製造方法
JP2009291073A (ja) * 2006-09-22 2009-12-17 Chiome Bioscience Inc 抗体のクラスを変換する方法
JP2008099602A (ja) * 2006-10-19 2008-05-01 Institute Of Physical & Chemical Research 抗体遺伝子の可変領域における変異部位の分布状況の調節法
JP5537420B2 (ja) * 2007-05-31 2014-07-02 ユニヴァーシティ オブ ワシントン 標的遺伝子の誘導性変異誘発
EP2374881A4 (de) 2008-12-05 2013-03-13 Chiome Bioscience Inc Verfahren zur herstellung eines gegen zelloberflächenexprimiertes protein gerichteten antikörpers
US8901044B2 (en) * 2009-05-13 2014-12-02 Riken Method to prepare magnetic beads conjugated with small compounds
JP5158816B2 (ja) * 2009-10-19 2013-03-06 国立大学法人 東京大学 キメラ抗体の一段階作製方法
RU2014115676A (ru) 2011-09-21 2015-10-27 Фуджиребайо Инк. Антитела против аффинного комплекса
EP2825652B1 (de) 2012-03-15 2018-09-05 Omeros Corporation Zusammensetzung und verfahren zur diversifizierung von zielsequenzen
US20160187325A1 (en) 2013-08-21 2016-06-30 Fujirebio Inc. Method and kit for measuring modified nucleobase using heterogeneous nucleic acid probe
EP3037532A4 (de) 2013-08-21 2017-05-03 Fujirebio Inc. Verfahren zur messung modifizierter nukleobasen durch verwendung einer festphasensonde und kit dafür
EP3037535A4 (de) 2013-08-21 2017-04-05 Fujirebio Inc. Verfahren zur messung einer modifizierten nukleinsäurebase mit einem absorbierenden polynukleotid und kit dafür
EP3098311A4 (de) 2014-01-20 2017-09-06 Fujirebio Inc. Verfahren zur messung einer modifizierten nukleobase mit führungssonde und kit dafür
EP3851453A1 (de) * 2014-05-02 2021-07-21 Chiome Bioscience Inc. Zellen zur herstellung eines humanen antikörpers
US11008566B2 (en) 2016-09-30 2021-05-18 Chiome Bioscience Inc. Method for obtaining antibody
JP7071740B2 (ja) 2017-02-10 2022-05-19 株式会社カイオム・バイオサイエンス 抗体可変領域の多様化を促進する方法
JP7325336B2 (ja) 2017-12-25 2023-08-14 富士レビオ株式会社 マクロライド系免疫抑制剤についての血液検査方法
CN118459597A (zh) 2019-12-27 2024-08-09 凯奥目生物科学株式会社 抗cdcp1抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022111A1 (en) * 1998-10-09 2000-04-20 Medical Research Council Method for generating diversity
US7122339B2 (en) 1998-10-09 2006-10-17 Medical Research Council Method for generating diversity
CN1345935A (zh) * 2000-09-26 2002-04-24 上海博德基因开发有限公司 一种新的多肽——人组蛋白去乙酰基酶12.98和编码这种多肽的多核苷酸
EP1506288B1 (de) 2002-05-10 2013-04-17 Medical Research Council Aktivierungsinduzierte deaminase (aid)

Also Published As

Publication number Publication date
US7776599B2 (en) 2010-08-17
EP1536004A1 (de) 2005-06-01
CN100379862C (zh) 2008-04-09
CN1671842A (zh) 2005-09-21
EP1536004A4 (de) 2006-06-14
JPWO2004011644A1 (ja) 2005-11-24
JP4214234B2 (ja) 2009-01-28
US8187884B2 (en) 2012-05-29
US20110070650A1 (en) 2011-03-24
EP1536004B1 (de) 2010-12-01
US20060183225A1 (en) 2006-08-17
WO2004011644A1 (ja) 2004-02-05
DE60335191D1 (de) 2011-01-13

Similar Documents

Publication Publication Date Title
ATE490314T1 (de) Verfahren zur förderung der homologen rekombination somatischer zellen und verfahren zur konstruktion eines spezifischen antikörpers
CY1110557T1 (el) Αντισωματα ιντερλευκινης-10
PE20141162A1 (es) Anticuerpos anti-il-23
RU2018119366A (ru) Мыши с гуманизированной легкой цепью
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
DE602006021324D1 (de) Verfahren zur herstellung stabiler b-lymphozyten
NZ716369A (en) Anti-ox40 antibodies and methods of using the same
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
WO2010027488A3 (en) Monoclonal antibodies
MX2011010027A (es) Anticuerpos solubles "solo de cadena pesada".
HRP20140419T1 (hr) Molekule za vezanje koje mogu neutralizirati virus bjesnoä†e i njihova uporaba
CN1617938A (zh) 从单个样品中分离核酸和蛋白质的方法
ATE477277T1 (de) Weniger immunogene bindungsmoleküle
RS52782B (en) HIGH AFINITY HUMAN ANTIBODIES FOR THE HUMAN IL-4 RECEPTOR
BRPI0821682A2 (pt) Anticorpo monoclonal ou uma sua porção ligante de antígeno, composição farmacêutica, métodos para tratar uma doença imunológica e para produzir o anticorpo monoclonal ou sua porção ligante de antígeno, linhagem de célula isolada, molécula de ácido nucleico isolada, vetor, célula hospedeira, e, processo para identificar anticorpos anti-mif.
DE502006009060D1 (de) Verfahren zur fermentativen Herstellung von Antikörpern
RS53594B1 (en) PREPARAT HER2 ANTITELA
GEP20104991B (en) Antibodies that bind interleukin-4 receptor
JP2012143232A5 (de)
WO2009088924A3 (en) Methods and materials for targeted affinity enhancement
UA95329C2 (ru) Собачий тимусный стромальный лимфопоэтин и его применение
WO2006061723A3 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
PL439807A1 (pl) Sposoby oczyszczania przeciwciał i ich kompozycje
EP3103810A3 (de) Modifizierte moleküle mit variablen domänen sowie herstellungs- und verwendungsverfahren dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties